Vertex Pharmaceuticals Incorporated
Materials and methods for treatment of Duchenne Muscular Dystrophy

Abstract:

The present application provides materials and methods for treating a patient with Duchenne Muscular Dystrophy (DMD) both ex vivo and in vivo. In addition, the present application provides materials and methods for editing a dystrophin gene in a cell by genome editing.